Cargando…

Far-Infrared Therapy Improves Arteriovenous Fistula Patency and Decreases Plasma Asymmetric Dimethylarginine in Patients with Advanced Diabetic Kidney Disease: A Prospective Randomized Controlled Trial

Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase and plays a significant role in the pathogenesis of arteriovenous fistula (AVF) dysfunction. The aim of this study is to evaluate the effect of far-infrared (FIR) therapy on the maturation and patency of newly-cre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chun-Fan, Lee, Chiu-Yang, Chen, Fu-An, Yang, Chih-Yu, Chen, Tz-Heng, Ou, Shuo-Ming, Lee, Kuo-Hua, Li, Ching-Po, Chan, Chia-Hao, Lee, Pui-Ching, Chen, Yung-Tai, Lee, Tsung-Lun, Ho, Yang, Chen, Fan-Yu, Ma, Hao-Wei, Chen, Jinn-Yang, Tan, Ann Charis, Li, Szu-Yuan, Lin, Chih-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325296/ https://www.ncbi.nlm.nih.gov/pubmed/35887935 http://dx.doi.org/10.3390/jcm11144168

Ejemplares similares

The Effect of Far-Infrared Therapy on the Peritoneal Membrane Transport Characteristics of Uremic Patients Undergoing Peritoneal Dialysis: An Open-Prospective Proof-of-Concept Study
por: Li, Ching-Po, et al.
Publicado: (2021)

The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis
por: Chang, Chia-Ning, et al.
Publicado: (2021)

Weight-Based Assessment of Access Flow Threshold to Predict Arteriovenous Fistula Functional Patency
por: Yang, Chih-Yu, et al.
Publicado: (2021)

Key pathological features characterize minimal change disease-like IgA nephropathy
por: Wang, Tsung-Yueh, et al.
Publicado: (2023)

Prognosis of Vascular Access in Haemodialysis Patients with Autosomal Dominant Polycystic Kidney Disease
por: Lee, Tsung-Lun, et al.
Publicado: (2020)

Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
por: Lee, Tzong-Shyuan, et al.
Publicado: (2021)

Statins Improve Long Term Patency of Arteriovenous Fistula for Hemodialysis
por: Chang, Hao-Hsiang, et al.
Publicado: (2016)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017)

Renal asymmetric dimethylarginine inhibits fibrosis
por: Wu, Ming, et al.
Publicado: (2020)

Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis
por: Chen, Fu-An, et al.
Publicado: (2016)

Asymmetric Dimethylarginine Is Associated with Developmental Programming of Adult Kidney Disease and Hypertension in Offspring of Streptozotocin-Treated Mothers
por: Tain, You-Lin, et al.
Publicado: (2013)

Long-term prognosis of vascular access in hemodialysis patients with systemic lupus erythematosus: a retrospective cohort study
por: Chen, Fan-Yu, et al.
Publicado: (2021)

Asymmetric dimethylarginine compartmental behavior during high-flux hemodialysis
por: Du, Qiuna, et al.
Publicado: (2020)

The Associations between Erythropoietic Response with Inflammation Markers and Perfluorinated Chemicals in Hemodialysis Patients
por: Liu, Wen-Sheng, et al.
Publicado: (2023)

Stent grafts improved patency of ruptured hemodialysis vascular accesses
por: Liao, Min-Tsun, et al.
Publicado: (2022)

Roles of Nitric Oxide and Asymmetric Dimethylarginine in Pregnancy and Fetal Programming
por: Huang, Li-Tung, et al.
Publicado: (2012)

Peritoneal-Membrane Characteristics and Hypervolemia Management in Peritoneal Dialysis: A Randomized Control Trial
por: Li, Szu-Yuan, et al.
Publicado: (2021)

Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
por: Xie, Ziang, et al.
Publicado: (2022)

Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022)

Judicious use of sodium-glucose cotransporter 2 inhibitors in patients with diabetes on coronavirus-19 pandemic
por: Chen, Chun-Fan, et al.
Publicado: (2020)

Effect of far-infrared radiation therapy on von Willebrand factor in patients with chronic kidney disease
por: Yen, Cheng-Chieh, et al.
Publicado: (2023)

Tumor cell-derived asymmetric dimethylarginine regulates macrophage functions and polarization
por: Chen, Yi-Ling, et al.
Publicado: (2022)

Baseline Peritoneal Membrane Transport Characteristics Are Associated with Peritonitis Risk in Incident Peritoneal Dialysis Patients
por: Chou, Yi-Hsin, et al.
Publicado: (2022)

Ankle-Brachial Index Is a Powerful Predictor of Renal Outcome and Cardiovascular Events in Patients with Chronic Kidney Disease
por: Chen, Fu-An, et al.
Publicado: (2012)

Validity of the Age-Adjusted Charlson Comorbidity Index on Clinical Outcomes for Patients with Nasopharyngeal Cancer Post Radiation Treatment: A 5-Year Nationwide Cohort Study
por: Yang, Ching-Chieh, et al.
Publicado: (2015)

Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula
por: Chang, Te-I., et al.
Publicado: (2020)

Plasma Asymmetric Dimethylarginine and Adverse Events in Patients with Atrial Fibrillation Referred for Coronary Angiogram
por: Chao, Tze-Fan, et al.
Publicado: (2013)

Protein arginine methyltransferase 3 inhibits renal tubulointerstitial fibrosis through asymmetric dimethylarginine
por: Wang, Yanzhe, et al.
Publicado: (2022)

The prognostic value of asymmetric dimethylarginine in patients with cardiac syndrome X
por: Lu, Tse-Min, et al.
Publicado: (2017)

Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia
por: Tenderenda-Banasiuk, Edyta, et al.
Publicado: (2013)

Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis
por: Moon, Ju-Young, et al.
Publicado: (2015)

α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression
por: Qian, Jing, et al.
Publicado: (2021)

Plasma asymmetric dimethylarginine is associated with vulnerable plaque and long-term outcomes in stable coronary artery disease
por: Huang, Shao-Sung, et al.
Publicado: (2023)

Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats
por: Zheng, Dongdan, et al.
Publicado: (2015)

Association of stiff-person syndrome with autoimmune endocrine diseases
por: Lee, Yi-Yin, et al.
Publicado: (2019)

Characterizing Tyrosinase Modulators from the Roots of Angelica keiskei Using Tyrosinase Inhibition Assay and UPLC-MS/MS as the Combinatorial Novel Approach
por: Lee, Jia-Hao, et al.
Publicado: (2019)

Comparison of Elixhauser and Charlson Methods for Predicting Oral Cancer Survival
por: Chang, Heng-Jui, et al.
Publicado: (2016)

Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
por: Aldámiz-Echevarría, Luis, et al.
Publicado: (2012)

Arginine/Asymmetric Dimethylarginine Ratio in Colorectal Surgery
por: Ragina, Neli, et al.
Publicado: (2017)

Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle
por: Lee, Woojung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rmpqlcgut5v7a5b7amjbdj3f7r